Cargando…
Lineage Differentiation Potential of Different Sources of Mesenchymal Stem Cells for Osteoarthritis Knee
Tissue engineering and regenerative medicine (TERM) have paved a way for treating musculoskeletal diseases in a minimally invasive manner. The regenerative medicine cocktail involves the usage of mesenchymal stem/stromal cells (MSCs), either uncultured or culture-expanded cells along with growth fac...
Autores principales: | Prajwal, Gollahalli Shivashankar, Jeyaraman, Naveen, Kanth V, Krishna, Jeyaraman, Madhan, Muthu, Sathish, Rajendran, Sree Naga Sowndary, Rajendran, Ramya Lakshmi, Khanna, Manish, Oh, Eun Jung, Choi, Kang Young, Chung, Ho Yun, Ahn, Byeong-Cheol, Gangadaran, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028477/ https://www.ncbi.nlm.nih.gov/pubmed/35455383 http://dx.doi.org/10.3390/ph15040386 |
Ejemplares similares
-
Osteogenic and Chondrogenic Potential of Periosteum-Derived Mesenchymal Stromal Cells: Do They Hold the Key to the Future?
por: Jeyaraman, Madhan, et al.
Publicado: (2021) -
Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective
por: Muthu, Sathish, et al.
Publicado: (2022) -
Impact of the Process Variables on the Yield of Mesenchymal Stromal Cells from Bone Marrow Aspirate Concentrate
por: Jeyaraman, Madhan, et al.
Publicado: (2022) -
Where Do We Stand in Stem Cell Therapy for the Management of Diabetes Mellitus?—A Scientometric Research Trend Analysis from 1990 to 2020
por: Muthu, Sathish, et al.
Publicado: (2021) -
Is Culture Expansion Necessary in Autologous Mesenchymal Stromal Cell Therapy to Obtain Superior Results in the Management of Knee Osteoarthritis?—Meta-Analysis of Randomized Controlled Trials
por: Muthu, Sathish, et al.
Publicado: (2021)